The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk

Journal of Diabetes and its Complications

Volumn 22, Issue 6, 2008, Pages 377-383

  Möllsten, Anna ^a   Kockum, Ingrid ^b   Svensson, Maria ^a   Rudberg, Susanne ^b   Ugarph Morawski, Anna ^b   Brismar, Kerstin ^b   Eriksson, Jan W ^a   Dahlquist, Gisela ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Diabetic nephropathy; Polymorphism; Smoking

Indexed keywords

ALBUMIN; ANGIOTENSIN 1 RECEPTOR; HEMOGLOBIN A1C;

ADULT; ALBUMINURIA; ALLELE; ANGIOTENSINOGEN GENE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE DURATION; FEMALE; GENE; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PRIORITY JOURNAL; QUESTIONNAIRE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADULT; ALBUMINURIA; ALLELES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HOMOZYGOTE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; SMOKING;

EID: 54049132935     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2007.06.005     Document Type: Article

References (37)

1. Atwood L.D., Kammerer C.M., Samollow P.B., Hixson J.E., Shade R.E., and MacCluer J.W. Linkage of essential hypertension to the angiotensinogen locus in Mexican Americans. Hypertension 30 3 Pt.1 (1997) 326-330
2. Baer L., and Radichevich I. Cigarette smoking in hypertensive patients. Blood pressure and endocrine responses. American Journal of Medicine 78 4 (1985) 564-568
3. Bradley M., Soderhall C., Luthman H., Wahlgren C.F., Kockum I., and Nordenskjold M. Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population. Human Molecular Genetics 11 13 (2002) 1539-1548
4. Brand E., Chatelain N., Mulatero P., Fery I., Curnow K., Jeunemaitre X., Corvol P., Pascoe L., and Soubrier F. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 32 2 (1998) 198-204
5. Caulfield M., Lavender P., Farrall M., Munroe P., Lawson M., Turner P., and Clark A.J. Linkage of the angiotensinogen gene to essential hypertension. New England Journal of Medicine 330 23 (1994) 1629-1633
6. Chowdhury T.A., Dyer P.H., Kumar S., Gough S.C., Gibson S.P., Rowe B.R., Smith P.R., Dronsfield M.J., Marshall S.M., Mackin P., Dean J.D., Morris P.J., Davies S., Dunger D.B., Boulton A.J., Barnett A.H., and Bain S.C. Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus. Diabetic Medicine 14 10 (1997) 837-840
7. Christiansen J.S. Cigarette smoking and prevalence of microangiopathy in juvenile-onset insulin-dependent diabetes mellitus. Diabetes Care 1 3 (1978) 146-149
8. Coll E., Campos B., Gonzalez-Nunez D., Botey A., and Poch E. Association between the A1166C polymorphism of the angiotensin II receptor type 1 and progression of chronic renal insufficiency. Journal of Nephrology 16 3 (2003) 357-364
9. Davies E., Bonnardeaux A., Lathrop G.M., Corvol P., Clauser E., and Soubrier F. Angiotensin II (type-1) receptor locus: CA repeat polymorphism and genetic mapping. Human Molecular Genetics 3 5 (1994) 838
10. Diez J., Laviades C., Orbe J., Zalba G., Lopez B., Gonzalez A., Mayor G., Paramo J.A., and Beloqui O. The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives. Journal of Hypertension 21 11 (2003) 2085-2092
11. Doria A., Ji L., Warram J.H., and Krolewski A.S. DdeI polymorphism in the AGTR1 gene. Human Molecular Genetics 3 8 (1994) 1444
12. Doria A., Onuma T., Warram J.H., and Krolewski A.S. Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia 40 11 (1997) 1293-1299
13. Doria A., Warram J.H., and Krolewski A.S. Genetic susceptibility to nephropathy in insulin-dependent diabetes: From epidemiology to molecular genetics. Diabetes/Metabolism Reviews 11 4 (1995) 287-314
14. Fujisawa T., Ikegami H., Kawaguchi Y., Hamada Y., Ueda H., Shintani M., Fukuda M., and Ogihara T. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41 1 (1998) 47-53
15. Gunning M.E., Ingelfinger J.R., King A.J., and Brenner B.M. Vasoactive peptides and the kidney. In: Brenner B.M., and Rector F.J. (Eds). The kidney. 6th ed. (1996), W.B. Saunders Company, Philadelphia 627-649
16. Hengstenberg C., Holmer S.R., Mayer B., Lowel H., Engel S., Hense H.W., Riegger G.A., and Schunkert H. Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction. Hypertension 35 3 (2000) 704-709
17. Ishigami T., Umemura S., Tamura K., Hibi K., Nyui N., Kihara M., Yabana M., Watanabe Y., Sumida Y., Nagahara T., Ochiai H., and Ishii M. Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension 30 6 (1997) 1325-1330
18. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., Lifton R.P., Williams C.S., Charru A., Hunt S.C., Hopkins P.N., Williams R.R., Lalouel J.M., et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 71 1 (1992) 169-180
19. Kirschbaum C., Wust S., and Strasburger C.J. 'Normal' cigarette smoking increases free cortisol in habitual smokers. Life Sciences 50 6 (1992) 435-442
20. Kotelevtsev Yu V., Clauser E., Corvol P., and Soubrier F. Dinucleotide repeat polymorphism in the human angiotensinogen gene. Nucleic Acids Research 19 24 (1991) 6978
21. Lindholm L.H., Ibsen H., Dahlof B., Devereux R.B., Beevers G., de Faire U., Fyhrquist F., Julius S., Kjeldsen S.E., Kristiansson K., Lederballe-Pedersen O., Nieminen M.S., Omvik P., Oparil S., Wedel H., Aurup P., Edelman J., and Snapinn S. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 359 9311 (2002) 1004-1010
22. Lindpaintner K., Pfeffer M.A., Kreutz R., Stampfer M.J., Grodstein F., LaMotte F., Buring J., and Hennekens C.H. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. New England Journal of Medicine 332 11 (1995) 706-711
23. Mogensen C.E., and Christensen C.K. Predicting diabetic nephropathy in insulin-dependent patients. New England Journal of Medicine 311 2 (1984) 89-93
24. Ng D.P., Tai B.C., Koh D., Tan K.W., and Chia K.S. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: A meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 48 5 (2005) 1008-1016
25. Perkins B.A., Ficociello L.H., Silva K.H., Finkelstein D.M., Warram J.H., and Krolewski A.S. Regression of microalbuminuria in type 1 diabetes. New England Journal of Medicine 348 23 (2003) 2285-2293
26. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Journal of Clinical Investigation 86 4 (1990) 1343-1346
27. Rigat B., Hubert C., Corvol P., and Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Research 20 6 (1992) 1433
28. Righetti M., and Sessa A. Cigarette smoking and kidney involvement. Journal of Nephrology 14 1 (2001) 3-6
29. Rothman K.J. Modern epidemiology. 1st ed. (1986), Little, Brown and Company, Boston
30. Rudberg S., Aperia A., Freyschuss U., and Persson B. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 33 8 (1990) 470-476
31. Rudberg S., Osterby R., Dahlquist G., Nyberg G., and Persson B. Predictors of renal morphological changes in the early stage of microalbuminuria in adolescents with IDDM. Diabetes Care 20 3 (1997) 265-271
32. Rudberg S., Stattin E.L., and Dahlquist G. Familial and perinatal risk factors for micro- and macroalbuminuria in young IDDM patients. Diabetes 47 7 (1998) 1121-1126
33. Scott L.J., Warram J.H., Hanna L.S., Laffel L.M., Ryan L., and Krolewski A.S. A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 50 12 (2001) 2842-2849
34. Shanmugam V., Sell K.W., and Saha B.K. Mistyping ACE heterozygotes. PCR Methods and Applications 3 2 (1993) 120-121
35. van Geel P.P., Pinto Y.M., Voors A.A., Buikema H., Oosterga M., Crijns H.J., and van Gilst W.H. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 35 3 (2000) 717-721
36. Viberti G.C., Hill R.D., Jarrett R.J., Argyropoulos A., Mahmud U., and Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1 8287 (1982) 1430-1432
37. Viberti G.C., Keen H., and Wiseman M.J. Raised arterial pressure in parents of proteinuric insulin dependent diabetics. British Medical Journal (Clin Res Ed) 295 6597 (1987) 515-517